Germline CEBPA mutation in familial acute myeloid leukemia

Myeloid Neoplasms with germline predisposition become part of 2016 World Health Organization (WHO) classification of hematological malignancies since 2016. CCAAT/enhancer binding protein-alpha (CEBPA) is a myeloid transcription factor located in chromosome 19q. Acute myeloid leukemia (AML) with bial...

Full description

Bibliographic Details
Main Authors: Matilde Boada, Ana Inés Catalan, Carolin Ottati, Florencia Bentancour, Daniela Lens, Cecilia Guillermo, Sofia Grille
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Hematology Reports
Subjects:
Online Access:https://www.pagepress.org/journals/index.php/hr/article/view/9114
_version_ 1797936677559205888
author Matilde Boada
Ana Inés Catalan
Carolin Ottati
Florencia Bentancour
Daniela Lens
Cecilia Guillermo
Sofia Grille
author_facet Matilde Boada
Ana Inés Catalan
Carolin Ottati
Florencia Bentancour
Daniela Lens
Cecilia Guillermo
Sofia Grille
author_sort Matilde Boada
collection DOAJ
description Myeloid Neoplasms with germline predisposition become part of 2016 World Health Organization (WHO) classification of hematological malignancies since 2016. CCAAT/enhancer binding protein-alpha (CEBPA) is a myeloid transcription factor located in chromosome 19q. Acute myeloid leukemia (AML) with biallelic mutations of CEBPA AML with recurrent genetic abnormalities according to WHO classification. The inheritance of a germline CEBPA mutation predisposes to the development of AML with autosomal dominant inheritance. Familial CEBPA AML share characteristics with somatic CEBPA AML. However, a higher relapse incidence is reported. We present the case of a 46-years-old male with family history of acute leukemia who was diagnosed with single mutated CEBPA acute myeloid leukemia. The same mutation was found in two of his siblings. The clinical suspicion and proper diagnosis of familial cases is necessary, especially when a related allogenic transplant is indicated in order to select an adequate donor.
first_indexed 2024-04-10T18:34:06Z
format Article
id doaj.art-5a15b7fdb7e048eab1df410d299d93f8
institution Directory Open Access Journal
issn 2038-8322
2038-8330
language English
last_indexed 2024-04-10T18:34:06Z
publishDate 2021-10-01
publisher MDPI AG
record_format Article
series Hematology Reports
spelling doaj.art-5a15b7fdb7e048eab1df410d299d93f82023-02-02T02:20:28ZengMDPI AGHematology Reports2038-83222038-83302021-10-0113310.4081/hr.2021.9114Germline CEBPA mutation in familial acute myeloid leukemiaMatilde Boada0Ana Inés Catalan1Carolin Ottati2Florencia Bentancour3Daniela Lens4Cecilia Guillermo5Sofia Grille6Hematology Department, Hospital de Clínicas Dr. Manuel Quinela, MontevideoBasic Medicine Department, Hospital de Clínicas Dr. Manuel Quinela, MontevideoBasic Medicine Department, Hospital de Clínicas Dr. Manuel Quinela, MontevideoHematology Department, Hospital de Clínicas Dr. Manuel Quinela, MontevideoBasic Medicine Department, Hospital de Clínicas Dr. Manuel Quinela, MontevideoHematology Department, Hospital de Clínicas Dr. Manuel Quinela, MontevideoHematology Department, and Basic Medicine Department, Hospital de Clínicas Dr. Manuel Quinela, MontevideoMyeloid Neoplasms with germline predisposition become part of 2016 World Health Organization (WHO) classification of hematological malignancies since 2016. CCAAT/enhancer binding protein-alpha (CEBPA) is a myeloid transcription factor located in chromosome 19q. Acute myeloid leukemia (AML) with biallelic mutations of CEBPA AML with recurrent genetic abnormalities according to WHO classification. The inheritance of a germline CEBPA mutation predisposes to the development of AML with autosomal dominant inheritance. Familial CEBPA AML share characteristics with somatic CEBPA AML. However, a higher relapse incidence is reported. We present the case of a 46-years-old male with family history of acute leukemia who was diagnosed with single mutated CEBPA acute myeloid leukemia. The same mutation was found in two of his siblings. The clinical suspicion and proper diagnosis of familial cases is necessary, especially when a related allogenic transplant is indicated in order to select an adequate donor.https://www.pagepress.org/journals/index.php/hr/article/view/9114Familial leukemiaCEBPAgermline predispositionacute myeloid leukemia
spellingShingle Matilde Boada
Ana Inés Catalan
Carolin Ottati
Florencia Bentancour
Daniela Lens
Cecilia Guillermo
Sofia Grille
Germline CEBPA mutation in familial acute myeloid leukemia
Hematology Reports
Familial leukemia
CEBPA
germline predisposition
acute myeloid leukemia
title Germline CEBPA mutation in familial acute myeloid leukemia
title_full Germline CEBPA mutation in familial acute myeloid leukemia
title_fullStr Germline CEBPA mutation in familial acute myeloid leukemia
title_full_unstemmed Germline CEBPA mutation in familial acute myeloid leukemia
title_short Germline CEBPA mutation in familial acute myeloid leukemia
title_sort germline cebpa mutation in familial acute myeloid leukemia
topic Familial leukemia
CEBPA
germline predisposition
acute myeloid leukemia
url https://www.pagepress.org/journals/index.php/hr/article/view/9114
work_keys_str_mv AT matildeboada germlinecebpamutationinfamilialacutemyeloidleukemia
AT anainescatalan germlinecebpamutationinfamilialacutemyeloidleukemia
AT carolinottati germlinecebpamutationinfamilialacutemyeloidleukemia
AT florenciabentancour germlinecebpamutationinfamilialacutemyeloidleukemia
AT danielalens germlinecebpamutationinfamilialacutemyeloidleukemia
AT ceciliaguillermo germlinecebpamutationinfamilialacutemyeloidleukemia
AT sofiagrille germlinecebpamutationinfamilialacutemyeloidleukemia